Journal of Biological Chemistry
Volume 277, Issue 16, 19 April 2002, Pages 13827-13830
Journal home page for Journal of Biological Chemistry

MECHANISMS OF SIGNAL TRANSDUCTION
Activator of G-protein Signaling 1 Blocks GIRK Channel Activation by a G-protein-coupled Receptor: APPARENT DISRUPTION OF RECEPTOR SIGNALING COMPLEXES*

https://doi.org/10.1074/jbc.M201064200Get rights and content
Under a Creative Commons license
open access

The Ras-related protein, activator ofG-protein signaling 1 (AGS1) or Dexras1, interacts with Gi/Goα and activates heterotrimeric G-protein signaling systems independent of a G-protein-coupled receptor (GPCR). As an initial approach to further define the cellular role of AGS1 in GPCR signaling, we determined the influence of AGS1 on the regulation of Gβγ-regulated inwardly rectifying K+ channel (GIRK) current (IACh) by M2-muscarinic receptor (M2-MR) in Xenopus oocytes. AGS1 expression inhibited receptor-mediated current activation by >80%. Mutation of a key residue (G31V) within the G1 domain involved in nucleotide binding for Ras-related proteins eliminated the action of AGS1. The inhibition of IACh was not overcome by increasing concentrations of the muscarinic agonist acetylcholine but was progressively lost upon injection of increasing amounts of M2-MR cRNA. These data suggest that AGS1 may antagonize GPCR signaling by altering the pool of heterotrimeric G-proteins available for receptor coupling and/or disruption of a preformed signaling complex. Such regulation would be of particular importance for those receptors that exist precoupled to heterotrimeric G-protein and for receptors operating within signaling complexes.

Cited by (0)

Published, JBC Papers in Press, February 12, 2002, DOI 10.1074/jbc.M201064200

*

This work was supported by National Institutes of Health Grants RO1-NS24821 and MH 59331 (to S. M. L.) and K01 AA00287 (to M. W. N.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Present address: The Guthrie Foundation, Sayre, PA 18840.

§

Present address: Millennium Pharmaceuticals, Inc., 640 Memorial Dr., Cambridge, MA 02139.